II
IRWD icon

Inspire Investing’s Ironwood Pharmaceuticals IRWD Stock Holding History

Inspire Investing’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.79M Buy
+509,941
New +$2.09M 0.1% 222
2025
Q3 		– Sell
-552,420
Closed -$396K – 901
2025
Q2 		$396K Buy
552,420
+320,595
+138% +$252K 0.04% 352
2025
Q1 		$341K Buy
231,825
+142,574
+160% +$340K 0.04% 692
2024
Q4 		$395K Sell
89,251
-11,778
-12% -$47.8K 0.04% 746
2024
Q3 		$416K Buy
101,029
+46,352
+85% +$249K 0.04% 378
2024
Q2 		$356K Buy
54,677
+13,908
+34% +$98.4K 0.04% 384
2024
Q1 		$355K Buy
40,769
+6,992
+21% +$84.8K 0.04% 757
2023
Q4 		$386K Buy
33,777
+2,108
+7% +$20.9K 0.04% 448
2023
Q3 		$305K Buy
31,669
+2,294
+8% +$22.5K 0.04% 745
2023
Q2 		$313K Sell
29,375
-45,444
-61% -$488K 0.04% 724
2023
Q1 		$787K Buy
74,819
+55,958
+297% +$627K 0.1% 177
2022
Q4 		$234K Sell
18,861
-2,120
-10% -$24K 0.03% 729
2022
Q3 		$217K Buy
20,981
+2,690
+15% +$30.5K 0.03% 337
2022
Q2 		$211K Sell
18,291
-509
-3% -$6K 0.03% 667
2022
Q1 		$237K Sell
18,800
-2,216
-11% -$25.4K 0.03% 423
2021
Q4 		$245K Buy
21,016
+3,592
+21% +$44.1K 0.03% 728
2021
Q3 		$228K Sell
17,424
-11,814
-40% -$153K 0.03% 633
2021
Q2 		$376K Buy
29,238
+886
+3% +$10.1K 0.05% 473
2021
Q1 		$317K Buy
28,352
+8,636
+44% +$91.2K 0.05% 507
2020
Q4 		$225K Buy
+19,716
New +$216K 0.05% 579
2020
Q3 		– Sell
-22,134
Closed -$228K – 500
2020
Q2 		$228K Buy
22,134
+751
+4% +$7.69K 0.08% 354
2020
Q1 		$216K Buy
21,383
+8,468
+66% +$99.5K 0.09% 372
2019
Q4 		$172K Sell
12,915
-6,823
-35% -$75.2K 0.06% 333
2019
Q3 		$169K Buy
19,738
+4,333
+28% +$42.1K 0.06% 362
2019
Q2 		$169K Buy
15,405
+1,818
+13% +$20.4K 0.07% 309
2019
Q1 		$154K Buy
+13,587
New +$152K 0.07% 281
2018
Q1 		– Sell
-4,131
Closed -$52K – 444
2017
Q4 		$52K Buy
+4,131
New +$54K 0.04% 724

Other funds holding IRWD

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Inspire Investing's IRWD Position: Q1 2026 in Review

Inspire Investing opened a new position in Ironwood Pharmaceuticals (IRWD) in Q1 2026: 509,941 shares worth $1.79M. The stake represents 0.1% of the portfolio and ranks #222 among its holdings. This is a return to the name: Inspire Investing previously reported a position in IRWD as recently as Q2 2025.

Inspire Investing first reported a position in IRWD in Q4 2017 and has held it in 27 quarters since. 226 funds tracked by Wall St. Rank hold IRWD as of Q1 2026.

  • Inspire Investing held 509,941 shares of Ironwood Pharmaceuticals worth $1.79M as of Q1 2026.
  • Ironwood Pharmaceuticals was a new Inspire Investing position in Q1 2026.
  • Ironwood Pharmaceuticals made up 0.1% of Inspire Investing's portfolio in Q1 2026, its #222 holding.
  • Inspire Investing first reported a position in Ironwood Pharmaceuticals in Q4 2017 and has held it in 27 quarters since.
  • 226 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q1 2026.

Based on Inspire Investing's 13F filing for Q1 2026, filed 23 Apr 2026.